Perspective Therapeutics, Inc. financial data

Symbol
CATX on NYSE
Location
2401 Elliott Avenue, Suite 320, Seattle, WA
State of incorporation
DE
Fiscal year end
December 31
Former names
IsoRay, Inc. (to 2/16/2023), Isoray, Inc. (to 2/16/2023), CENTURY PARK PICTURES CORP (to 8/3/2005)
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.07K % +33.4%
Quick Ratio 18.2 % -64.6%
Debt-to-equity 17.2 % +97.8%
Return On Equity -31.7 % -42.8%
Return On Assets -27.1 % -32.5%
Operating Margin -93.7 % -91.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 67.4M shares -76%
Common Stock, Shares, Outstanding 67.4M shares -76%
Entity Public Float 186M USD +328%
Common Stock, Value, Issued 67K USD -76.1%
Weighted Average Number of Shares Outstanding, Basic 66.6M shares +138%
Weighted Average Number of Shares Outstanding, Diluted 66.6M shares +138%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.19M USD +27.3%
Research and Development Expense 29.4M USD +257%
Selling and Marketing Expense 855K USD +6.88%
General and Administrative Expense 20.8M USD +30.3%
Operating Income (Loss) -48.7M USD -97.1%
Nonoperating Income (Expense) 4.44M USD +275%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -44.3M USD -88.2%
Income Tax Expense (Benefit) -2.65M USD
Net Income (Loss) Attributable to Parent -59M USD -214%
Earnings Per Share, Basic 0.03 USD/shares +55%
Earnings Per Share, Diluted -0.18 USD/shares +55%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 252M USD +790%
Cash, Cash Equivalents, and Short-term Investments 293M USD
Accounts Receivable, after Allowance for Credit Loss, Current 142K USD -87.2%
Inventory, Net 1.01M USD -34.8%
Other Assets, Current 45K USD
Assets, Current 294M USD +821%
Property, Plant and Equipment, Net 14.7M USD +109%
Operating Lease, Right-of-Use Asset 2.02M USD +151%
Intangible Assets, Net (Excluding Goodwill) 354K USD
Goodwill 24.1M USD -11.9%
Other Assets, Noncurrent 672K USD +17.3%
Assets 386M USD +221%
Employee-related Liabilities, Current 2.31M USD
Liabilities, Current 10.6M USD +23.5%
Deferred Income Tax Liabilities, Net 4.59M USD
Operating Lease, Liability, Noncurrent 1.45M USD +167%
Other Liabilities, Noncurrent 19K USD
Liabilities 44.9M USD +291%
Retained Earnings (Accumulated Deficit) -176M USD -50.3%
Stockholders' Equity Attributable to Parent 341M USD +214%
Liabilities and Equity 386M USD +221%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 13.8M USD
Net Cash Provided by (Used in) Financing Activities 166M USD
Net Cash Provided by (Used in) Investing Activities -47.3M USD -287%
Common Stock, Shares Authorized 750M shares 0%
Common Stock, Shares, Issued 67.4M shares -76%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 133M USD +760%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.1M USD -9.13%
Deferred Tax Assets, Valuation Allowance 30M USD +45.4%
Deferred Tax Assets, Gross 38.8M USD +88.6%
Operating Lease, Liability 2.17M USD +170%
Depreciation 346K USD +92.2%
Payments to Acquire Property, Plant, and Equipment 9.07M USD +4413%
Lessee, Operating Lease, Liability, to be Paid 2.44M USD +170%
Property, Plant and Equipment, Gross 16.3M USD +8.27%
Operating Lease, Liability, Current 720K USD +175%
Lessee, Operating Lease, Liability, to be Paid, Year Two 482K USD +51.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 949K USD +197%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 272K USD +178%
Lessee, Operating Lease, Liability, to be Paid, Year Three 320K USD +202%
Deferred Tax Assets, Operating Loss Carryforwards 26.8M USD +39.8%
Preferred Stock, Shares Authorized 7M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 283K USD
Deferred Tax Assets, Net of Valuation Allowance 11K USD
Share-based Payment Arrangement, Expense 2.32M USD -44.1%
Interest Expense 84 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%